Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Factor XI deficiency, autosomal dominant, 612416 (Congenital factor XI deficiency) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
F11 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 327 | 300 |
|
PreventionGenetics, part of Exact Sciences United States | 78 | 79 |
|
Molecular Haemostasis & Thrombosis Synnovis Analytics LLP - Guy's and St. Thomas' NHS Foundation Trust United Kingdom | 1 | 1 |
|
Coagulation Factor Deficiency Panel PreventionGenetics, part of Exact Sciences United States | 21 | 20 |
|
PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Factor XI Mutation Analysis (Ashkenazi Jewish) Quest Diagnostics Nichols Institute San Juan Capistrano United States | 1 | 1 |
|
FACTOR XI DEFICIENCY (HEMOPHILIA C) BioReference Health United States | 1 | 1 |
|
Clotting factor deficiency panel. 16-gene NGS panel. Genologica Medica Spain | 29 | 16 |
|
Bleeding disorder / coagulopathy panel. NGS panel of 62 genes. Genologica Medica Spain | 96 | 62 |
|
Faktör XI deficency genetic analysis Duzen Laboratories Duzen BBAGUAS Turkey | 1 | 1 |
|
Comprehensive Bleeding Disorder Panel Versiti Diagnostic Laboratories Versiti, Inc United States | 80 | 50 |
|
Natera, Inc. United States | 244 | 254 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.